Everest Medicines
Pharmaceuticals, 450 Lexington Ave, New York, 10017, United States, 201-500 Employees
Who is EVEREST MEDICINES
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. W...
Read More
-
Headquarters: 450 Lexington Ave, New York, New York, 10017, United States
-
Date Founded: 2017
-
Employees: 201-500
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from EVEREST MEDICINES
Everest Medicines Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Everest Medicines
Answer: Everest Medicines's headquarters are located at 450 Lexington Ave, New York, 10017, United States
Answer: Everest Medicines's official website is https://everestmedicines.com
Answer: Everest Medicines's revenue is $25 Million to $50 Million
Answer: Everest Medicines's SIC: 2834
Answer: Everest Medicines's NAICS: 325412
Answer: Everest Medicines has 201-500 employees
Answer: Everest Medicines is in Pharmaceuticals
Answer: Everest Medicines contact info: Phone number: Website: https://everestmedicines.com
Answer: Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in Greater China and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. The company's Series A round was led by C-Bridge Capital, a top-tier China healthcare private equity firm, with US $800 million under management.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month